Laboratory surveillance of Shiga toxin producing Escherichia coli in South Australia and the Hunter Health Area, New South Wales, Australia.
To estimate the prevalence of Shiga toxin producing Escherichia coli in Australia, bloody stool samples from two Australian locations were screened for the presence of Shiga toxin genes, stx1 and stx2. Four of 126 (3.2%) and 139 of 5,829 (2.4%) patients from the two locations had a positive polymerase chain reaction for Shiga toxin genes.
Doyle
Robyn
R
Infectious Diseases Laboratories, Institute of Medical and Veterinary Science, Adelaide, South Australia.
Watson
Kieda
K
Unicomb
Leanne E
LE
Lanser
Janice A
JA
Wise
Rolf
R
Ratcliff
Rod
R
Combs
Barry
B
Ferguson
John
J
D000328:Adult; D002675:Child, Preschool; D004926:Escherichia coli / Q000302:isolation & purification* / Q000378:metabolism; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000382:microbiology; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009517:New South Wales / Q000453:epidemiology; D011159:Population Surveillance; D022622:Shiga Toxin 1 / Q000096:biosynthesis* / Q000235:genetics; D022641:Shiga Toxin 2 / Q000096:biosynthesis* / Q000235:genetics; D013021:South Australia / Q000453:epidemiology
D022622:Shiga Toxin 1; D022641:Shiga Toxin 2